{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:37:07Z","timestamp":1792204627890,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021592","name":"Ekhaga Foundation","doi-asserted-by":"publisher","award":["2019-79"],"award-info":[{"award-number":["2019-79"]}],"id":[{"id":"10.13039\/501100021592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010890","name":"Central People's Government of the People's Republic of China Scholarship Programme","doi-asserted-by":"publisher","award":["202207060003"],"award-info":[{"award-number":["202207060003"]}],"id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lfs.2025.123438","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:13:07Z","timestamp":1738347187000},"page":"123438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characterizing COPD phenotypes with a targeted signaling lipids metabolomics approach"],"prefix":"10.1016","volume":"364","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Wernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rothgangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susy","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Ummels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmylou","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"de Jong-van Luxzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn D.","family":"de Kruif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida","family":"Kindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"van Wietmarschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123438_bb0005","unstructured":"R.B. Alvar Agusti, Bartolome R. Celli, et al, 2023 Global Strategy for Prevention, Diagnosis and Management of COPD. https:\/\/goldcopd.org\/archived-reports\/, 2023."},{"key":"10.1016\/j.lfs.2025.123438_bb0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1183\/09031936.00105513","article-title":"Respiratory health and disease in Europe: the new European lung white book","volume":"42","author":"Gibson","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2025.123438_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"Lopez-Campos","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.lfs.2025.123438_bb0020","doi-asserted-by":"crossref","unstructured":"D. Adeloye, P. Song, Y. Zhu, H. Campbell, A. Sheikh, I. Rudan, N.R.G.R.H. Unit, Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis, Lancet Respir. Med. 10 (2022) 447\u2013458. doi:https:\/\/doi.org\/10.1016\/S2213-2600(21)00511-7.","DOI":"10.1016\/S2213-2600(21)00511-7"},{"key":"10.1016\/j.lfs.2025.123438_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11095-014-1490-4","article-title":"Prediction of disease progression, treatment response and dropout in chronic obstructive pulmonary disease (COPD)","volume":"32","author":"Musuamba","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2025.123438_bb0030","article-title":"Global initiative for chronic obstructive lung disease: the changes made","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2025.123438_bb0035","first-page":"434","article-title":"The diagnosis and treatment of COPD and its comorbidities","volume":"120","author":"Kahnert","year":"2023","journal-title":"Dtsch. \u00c4rztebl. int."},{"key":"10.1016\/j.lfs.2025.123438_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105938","article-title":"Goals of COPD treatment: focus on symptoms and exacerbations","volume":"166","author":"Vogelmeier","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41533-018-0097-3","article-title":"The physical, mental, and social impact of COPD in a population-based sample: results from the longitudinal aging study Amsterdam","volume":"28","author":"Franssen","year":"2018","journal-title":"NPJ Prim Care Respir Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0050","doi-asserted-by":"crossref","unstructured":"E.H. Koolen, H.W. van Hees, R.C. van Lummel, R. Dekhuijzen, R.S. Djamin, M.A. Spruit, A.J. van 't Hul, \"Can do\" versus \"do do\": A Novel Concept to Better Understand Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease, J Clin Med. 8 (2019). doi:https:\/\/doi.org\/10.3390\/jcm8030340.","DOI":"10.3390\/jcm8030340"},{"key":"10.1016\/j.lfs.2025.123438_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.rmed.2016.07.015","article-title":"Burden of COPD in patients treated in different care settings in the Netherlands","volume":"118","author":"Smid","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s40279-020-01286-9","article-title":"Profiling of patients with COPD for adequate referral to exercise-based care: the Dutch model","volume":"50","author":"Spruit","year":"2020","journal-title":"Sports Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pulmoe.2019.10.006","article-title":"Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art","volume":"26","author":"Corlateanu","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.lfs.2025.123438_bb0070","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jaci.2018.02.035","article-title":"Chronic obstructive pulmonary disease subpopulations and phenotyping","volume":"141","author":"Segal","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2025.123438_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8108717","article-title":"Phenotypic variation in patients with chronic obstructive pulmonary disease in primary care","volume":"2016","author":"Beekman","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2025.123438_bb0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.mayocp.2017.03.020","article-title":"Chronic obstructive pulmonary disease phenotypes: implications for care","volume":"92","author":"Mirza","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.lfs.2025.123438_bb0085","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1513\/AnnalsATS.201808-533MG","article-title":"Targeting chronic obstructive pulmonary disease phenotypes, Endotypes, and biomarkers","volume":"15","author":"Garudadri","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.lfs.2025.123438_bb0090","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.202209-1748SO","article-title":"Phenotypes, Etiotypes, and Endotypes of exacerbations of chronic obstructive pulmonary disease","volume":"208","author":"Bhatt","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2025.123438_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1472-6882-12-197","article-title":"Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study","volume":"12","author":"Li","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jebm.12578","article-title":"Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022)","volume":"16","author":"Li","year":"2023","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116229","article-title":"Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease","volume":"307","author":"Cao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2025.123438_bb0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.arbres.2022.12.018","article-title":"Metabolomics in COPD","volume":"59","author":"Gea","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.lfs.2025.123438_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10408363.2022.2140329","article-title":"Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview","volume":"60","author":"Dasgupta","year":"2023","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.lfs.2025.123438_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/resp.13530","article-title":"Metabolomics in chronic lung diseases","volume":"25","author":"Nambiar","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.lfs.2025.123438_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.201410-1771OC","article-title":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes","volume":"191","author":"Bowler","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123278","article-title":"High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease","volume":"1201-1202","author":"Liu","year":"2022","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2025.123438_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9040061","article-title":"Metabolomics identifies novel blood biomarkers of pulmonary function and COPD in the general population","volume":"9","author":"Yu","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2025.123438_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12931-020-01507-9","article-title":"Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease","volume":"21","author":"Liu","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2025.123438_bb0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/COPD.S229505","article-title":"Plasma metabolomics and Lipidomics reveal perturbed metabolites in different disease stages of chronic obstructive pulmonary disease","volume":"15","author":"Zhou","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.lfs.2025.123438_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12931-020-01390-4","article-title":"Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO)","volume":"21","author":"Ghosh","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2025.123438_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342348","article-title":"A comprehensive UHPLC-MS\/MS method for metabolomics profiling of signaling lipids: markers of oxidative stress, immunity and inflammation","volume":"1297","author":"Yang","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.lfs.2025.123438_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.101387","article-title":"Cold-induced changes in plasma signaling lipids are associated with a healthier cardiometabolic profile independently of brown adipose tissue","volume":"5","author":"Jurado-Fasoli","year":"2024","journal-title":"Cell reports. Medicine."},{"key":"10.1016\/j.lfs.2025.123438_bb0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/clinem\/dgab773","article-title":"Plasma levels of bile acids are related to Cardiometabolic risk factors in Young adults","volume":"107","author":"Osuna-Prieto","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2025.123438_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00109-020-01907-w","article-title":"Signaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis","volume":"98","author":"Di Zazzo","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2025.123438_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-1-13","article-title":"Development, validity and responsiveness of the clinical COPD questionnaire","volume":"1","author":"van der Molen","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.lfs.2025.123438_bb0190","doi-asserted-by":"crossref","first-page":"46s","DOI":"10.1183\/09031936.03.00078002","article-title":"COPD exacerbations: definitions and classifications","volume":"41","author":"Burge","year":"2003","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.lfs.2025.123438_bb0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/bjsm.2004.013771","article-title":"Reliability and validity of a brief physical activity assessment for use by family doctors","volume":"39","author":"Marshall","year":"2005","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2025.123438_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"A.T.S.C.o.P.S.f.C.P.F. Laboratories","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0210","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thoraxjnl-2014-205228","article-title":"The first reference equations for the 6-minute walk distance over a 10 m course","volume":"69","author":"Beekman","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2025.123438_bb0215","first-page":"767","article-title":"Measure it super simple (MISS) activity tracker: (re)design of a user-friendly interface and evaluation of experiences in daily life, Disabil. Rehabil","volume":"17","author":"Ummels","year":"2022","journal-title":"Assist. Technol."},{"key":"10.1016\/j.lfs.2025.123438_bb0220","series-title":"Diagnosis in Chinese Medicine\u202f: A Comprehensive Guide, Churchill Livingstone","author":"Maciocia","year":"2004"},{"key":"10.1016\/j.lfs.2025.123438_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v032.i01","article-title":"Effect displays in R for multinomial and proportional-odds logit models: extensions to the effects package","volume":"32","author":"Fox","year":"2009","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.lfs.2025.123438_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B."},{"key":"10.1016\/j.lfs.2025.123438_bb0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","article-title":"Population marginal means in the linear model: An alternative to least squares means","volume":"34","author":"Searle","year":"1980","journal-title":"Am. Stat."},{"key":"10.1016\/j.lfs.2025.123438_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/875647939000600106","article-title":"Interpretation of the correlation-coefficient - a basic review","volume":"6","author":"Taylor","year":"1990","journal-title":"J Diagn Med Sonog."},{"key":"10.1016\/j.lfs.2025.123438_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2025.123438_bb0250","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1248\/bpb.b22-00304","article-title":"The many roles of Lysophospholipid mediators and Japanese contributions to this field","volume":"45","author":"Takagi","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2025.123438_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2020.11.119","article-title":"Structurally different lysophosphatidylethanolamine species stimulate neurite outgrowth in cultured cortical neurons via distinct G-protein-coupled receptors and signaling cascades","volume":"534","author":"Hisano","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.123438_bb0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jb\/mvab046","article-title":"Abundant oleoyl-lysophosphatidylethanolamine in brain stimulates neurite outgrowth and protects against glutamate toxicity in cultured cortical neurons","volume":"170","author":"Hisano","year":"2021","journal-title":"J. Biochem."},{"key":"10.1016\/j.lfs.2025.123438_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155122","article-title":"Targeting MAPK signaling: a promising approach for treating inflammatory lung disease","volume":"254","author":"Saleem","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2025.123438_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110747","article-title":"Lipidomic profiling identifies signatures of poor cardiovascular health","volume":"11","author":"Rivas Serna","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2025.123438_bb0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbi.2023.08.010","article-title":"Metabolomic profiles of chronic distress are associated with cardiovascular disease risk and inflammation-related risk factors","volume":"114","author":"Balasubramanian","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2025.123438_bb0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/imr.13204","article-title":"Emerging roles of lysophosphatidylserine as an immune modulator","volume":"317","author":"Yaginuma","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2025.123438_bb0285","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-protein-coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.123438_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/glia.22744","article-title":"Altered microglial phagocytosis in GPR34-deficient mice","volume":"63","author":"Preissler","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2025.123438_bb0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1084\/jem.20141827","article-title":"The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function","volume":"212","author":"Barnes","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108421","article-title":"Lysophosphatidic acid, a simple phospholipid with myriad functions","volume":"246","author":"Yanagida","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.123438_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133619","article-title":"Autotaxin and endotoxin-induced acute lung injury","volume":"10","author":"Mouratis","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2025.123438_bb0310","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fphys.2017.00155","article-title":"Adult lysophosphatidic acid receptor 1-deficient rats with hyperoxia-induced neonatal chronic lung disease are protected against lipopolysaccharide-induced acute lung injury","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2025.123438_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12989-022-00503-9","article-title":"Pro-thrombotic changes associated with exposure to ambient ultrafine particles in patients with chronic obstructive pulmonary disease: roles of lipid peroxidation and systemic inflammation","volume":"19","author":"Wang","year":"2022","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.lfs.2025.123438_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106314","article-title":"Changes in bioactive lipid mediators in response to short-term exposure to ambient air particulate matter: a targeted lipidomic analysis of oxylipin signaling pathways","volume":"147","author":"Wang","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.lfs.2025.123438_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687192","article-title":"12\/15-lipoxygenase regulates IL-33-induced eosinophilic airway inflammation in mice","volume":"12","author":"Miyata","year":"2021","journal-title":"Front. Immunol."},{"issue":"2023","key":"10.1016\/j.lfs.2025.123438_bb0330","article-title":"Arachidonic acid metabolism in health and disease","volume":"4","author":"Zhang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.lfs.2025.123438_bb0335","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/thx.2005.041830","article-title":"COPD exacerbations. 3: Pathophysiology","volume":"61","author":"O'Donnell","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2025.123438_bb0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12038-007-0028-x","article-title":"Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst","volume":"32","author":"Thompson","year":"2007","journal-title":"J. Biosci."},{"key":"10.1016\/j.lfs.2025.123438_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033780","article-title":"Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation","volume":"7","author":"Lundstrom","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2025.123438_bb0350","unstructured":"R.C.B. Gary S. Firestein, Sherine E. Gabriel, et al., Kelley's Textbook of Rheumatology. https:\/\/www.sciencedirect.com\/book\/9781437717389\/kelleys-textbook-of-rheumatology, 2013."},{"key":"10.1016\/j.lfs.2025.123438_bb0355","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.202106-1503OC","article-title":"Thromboxane-Prostanoid receptor signaling drives persistent fibroblast activation in pulmonary fibrosis","volume":"206","author":"Suzuki","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0360","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2025.123438_bb0365","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123438_bb0370","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.21037\/jtd.2016.11.08","article-title":"Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease","volume":"8","author":"Chen","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lfs.2025.123438_bb0375","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.intimp.2018.11.005","article-title":"Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice","volume":"66","author":"Fei","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2025.123438_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9080164","article-title":"Metabolomics-based studies assessing exercise-induced alterations of the human metabolome: a systematic review","volume":"9","author":"Sakaguchi","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2025.123438_bb0385","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/pr400717j","article-title":"Serum metabolic signatures induced by a three-day intensified exercise period persist after 14 h of recovery in runners","volume":"12","author":"Nieman","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.lfs.2025.123438_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101276","article-title":"Oxylipin profiling for clinical research: current status and future perspectives","volume":"95","author":"Parchem","year":"2024","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.lfs.2025.123438_bb0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40248-017-0084-5","article-title":"The physiological basis and clinical significance of lung volume measurements","volume":"12","author":"Lutfi","year":"2017","journal-title":"Multidiscip. Respir. Med."},{"key":"10.1016\/j.lfs.2025.123438_bb0400","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/ars.2017.7168","article-title":"The role of metabolite-sensing G protein-coupled receptors in inflammation and metabolic disease","volume":"29","author":"Recio","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2025.123438_bb0405","volume":"2","author":"Liu","year":"2017","journal-title":"NF-kappaB signaling in inflammation, Signal Transduct Target Ther."},{"key":"10.1016\/j.lfs.2025.123438_bb0410","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:54:26Z","timestamp":1741330466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S0024320525000712"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123438","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing COPD phenotypes with a targeted signaling lipids metabolomics approach","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123438"}}